237 related articles for article (PubMed ID: 21315426)
1. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency.
Kleywegt S; Pileggi V; Yang P; Hao C; Zhao X; Rocks C; Thach S; Cheung P; Whitehead B
Sci Total Environ; 2011 Mar; 409(8):1481-8. PubMed ID: 21315426
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
Boyd GR; Reemtsma H; Grimm DA; Mitra S
Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
[TBL] [Abstract][Full Text] [Related]
3. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds.
Stackelberg PE; Gibs J; Furlong ET; Meyer MT; Zaugg SD; Lippincott RL
Sci Total Environ; 2007 May; 377(2-3):255-72. PubMed ID: 17363035
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
Huerta-Fontela M; Galceran MT; Ventura F
Water Res; 2011 Jan; 45(3):1432-42. PubMed ID: 21122885
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system.
Kumar A; Xagoraraki I
Sci Total Environ; 2010 Nov; 408(23):5972-89. PubMed ID: 20869754
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
9. Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry.
Wang C; Shi H; Adams CD; Gamagedara S; Stayton I; Timmons T; Ma Y
Water Res; 2011 Feb; 45(4):1818-28. PubMed ID: 21185051
[TBL] [Abstract][Full Text] [Related]
10. Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry.
Zhao JL; Ying GG; Wang L; Yang JF; Yang XB; Yang LH; Li X
Sci Total Environ; 2009 Jan; 407(2):962-74. PubMed ID: 19004474
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea).
Yoon Y; Ryu J; Oh J; Choi BG; Snyder SA
Sci Total Environ; 2010 Jan; 408(3):636-43. PubMed ID: 19900699
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health.
Simazaki D; Kubota R; Suzuki T; Akiba M; Nishimura T; Kunikane S
Water Res; 2015 Jun; 76():187-200. PubMed ID: 25835589
[TBL] [Abstract][Full Text] [Related]
13. Analysis, occurrence and fate of commonly used pharmaceuticals and hormones in the Buyukcekmece Watershed, Turkey.
Aydin E; Talinli I
Chemosphere; 2013 Feb; 90(6):2004-12. PubMed ID: 23177011
[TBL] [Abstract][Full Text] [Related]
14. Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Al-Odaini NA; Zakaria MP; Yaziz MI; Surif S
J Chromatogr A; 2010 Oct; 1217(44):6791-806. PubMed ID: 20851398
[TBL] [Abstract][Full Text] [Related]
15. Mass flows of endocrine disruptors in the Glatt River during varying weather conditions.
Jonkers N; Kohler HP; Dammshäuser A; Giger W
Environ Pollut; 2009 Mar; 157(3):714-23. PubMed ID: 19117654
[TBL] [Abstract][Full Text] [Related]
16. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk.
Valcárcel Y; González Alonso S; Rodríguez-Gil JL; Gil A; Catalá M
Chemosphere; 2011 Sep; 84(10):1336-48. PubMed ID: 21641628
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
18. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources.
Focazio MJ; Kolpin DW; Barnes KK; Furlong ET; Meyer MT; Zaugg SD; Barber LB; Thurman ME
Sci Total Environ; 2008 Sep; 402(2-3):201-16. PubMed ID: 18433838
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California.
Fram MS; Belitz K
Sci Total Environ; 2011 Aug; 409(18):3409-17. PubMed ID: 21684580
[TBL] [Abstract][Full Text] [Related]
20. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time.
Gibs J; Stackelberg PE; Furlong ET; Meyer M; Zaugg SD; Lippincott RL
Sci Total Environ; 2007 Feb; 373(1):240-9. PubMed ID: 17188338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
